12 results
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
reputation and business prospects.
We have limited experience in drug discovery and drug development.
Because we in-licensed some of our investigational … caused to patients; and
harm to our reputation and resulting harm to physician or patient acceptance of our products.
Any of these events could
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
preliminary or interim data and final data could significantly harm our reputation and business prospects.
We have limited experience in drug discovery … actions;
initiation of legal action against us to hold us liable for harm caused to patients; and
harm to our reputation and resulting harm to physician
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
are available. Adverse differences between preliminary or interim data and final data could significantly harm our reputation and business prospects … to our reputation and resulting harm to physician or patient acceptance of our products.
Any of these events could prevent us from achieving
DRS
BHVN
Biohaven Ltd.
11 Oct 22
Draft registration statement
12:00am
the final data are available. Adverse differences between preliminary or interim data and final data could significantly harm our reputation … ;
initiation of legal action against us to hold us liable for harm caused to patients; and
harm to our reputation and resulting harm to physician
10-12B/A
EX-99.1
6psj3
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
7w3vwy63x1h gnaq5vz
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
dj2rnsad
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
j165atbqne4eebz56v
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-10.2
i2jame 7f
10 Aug 22
Registration of securities
5:07pm
10-12B
EX-99.1
j7j5upez
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
6igfi t5hwmwme6h6c8
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next